M. A. Bookman

Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.

M. A. Bookman, Henric Malmström, Giorgio Bolis et al. · Journal of Clinical Oncology · 1998 · 334 citations

Medicine, Oncology, Pharmacotherapy +16

Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions

M. A. Bookman, Dwight D. Kloth, P.E. Kover et al. · Annals of Oncology · 1997 · 115 citations · Full text

Medicine, Oncology, Pharmacology +12

Lymphocytic Lymphoma of Intermediate Differentiation: Morphologic, Immunophenotypic, and Prognostic Factors

M. A. Bookman, Pilar Lardelli, Elaine S. Jaffe et al. · JNCI Journal of the National Cancer Institute · 1990 · 64 citations

Medicine, Oncology, Pathology +15

Pharmacokinetic Model-Predicted Anticancer Drug Concentrations in Human Tumors

James M. Gallo, Paolo Vicini, Amy Orlansky et al. · Clinical Cancer Research · 2004 · 53 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Intravenous prophylaxis for paclitaxel-related hypersensitivity reactions.

M. A. Bookman, Dwight D. Kloth, P.E. Kover et al. · PubMed · 1997 · 33 citations

Medicine, Pharmacology, Pharmacotherapy +13